OSSIUM HEALTH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.ossiumhealth.com
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Ossium Health, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05589896
- Locations
- 🇺🇸
TriStar Bone Marrow Transplant, Nashville, Tennessee, United States
🇺🇸Columbia University - Herbert Irving Comprehensive Cancer Center, New York, New York, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Ossium Health, Inc.
- Registration Number
- NCT05443464
Mesenchymal Stem Cells (MSCs) for Perianal Fistula
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Ossium Health, Inc.
- Registration Number
- NCT05407766
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Ossium Health, Inc.
- Registration Number
- NCT05170828
© Copyright 2024. All Rights Reserved by MedPath